In the United States, more men with prostate cancer are being diagnosed with prostate-specific antigen < 10 ng/ml and stage cT1-cT2a; however, fewer are diagnosed with Gleason score 6 (likely due to 2005 changes in Gleason grading), which limits the number of men eligible for active surveillance.
Written by:
Weiner AB, Etzioni R, Eggener SE. Are you the author?
Section of Urology, University of Chicago Medical Center, Chicago, IL, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Reference: Eur Urol. 2014 Mar 4. pii: S0302-2838(14)00180-8.
doi: /10.1016/j.eururo.2014.02.051
PubMed Abstract
PMID: 24630416
UroToday.com Prostate Cancer Section
